Outcomes of Wilms tumor therapy in Lilongwe, Malawi, 2016–2021: Successes and ongoing research priorities
Pediatric Blood & Cancer · 2023
DOI: 10.1002/pbc.30242 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2023. Verfasst von David M Holmes und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Baylor College of Medicine, Houston, Texas, USA. Hauptthemen laut MEDLINE: Kidney Neoplasms, Wilms Tumor. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NICHD NIH HHS.
Abstract (Originalsprache)
Introduction
Wilms tumor therapy in low‐ and middle‐income countries (LMICs) relies on treatment protocols adapted to resource limitations, but these protocols have rarely been evaluated in real‐world settings. Such evaluations are necessary to identify high‐impact research priorities for clinical and implementation trials in LMICs. The purpose of this study was to identify highest priority targets for future clinical and implementation trials in sub‐Saharan Africa by assessing outcomes of a resource‐adapted treatment protocol in Malawi.
Methods
We conducted a retrospective cohort study of children treated for Wilms tumor with an adapted SIOP‐backbone protocol in Lilongwe, Malawi between 2016 and 2021. Survival analysis assessed variables associated with poor outcome with high potential for future research and intervention.
Results
We identified 136 patients, most commonly with stage III ( n = 35; 25.7%) or IV disease ( n = 35; 25.7%). Two‐year event‐free survival (EFS) was 54% for stage I/II, 51% for stage III, and 13% for stage IV. A single patient with stage V disease survived to 1 year. Treatment abandonment occurred in 36 (26.5%) patients. Radiotherapy was indicated for 55 (40.4%), among whom three received it. Of these 55 patients, 2‐year EFS was 31%. Of 14 patients with persistent metastatic pulmonary disease at the time of nephrectomy, none survived to 2 years. Notable variables independently associated with survival were severe acute malnutrition (hazard ratio [HR]: 1.9), increasing tumor stage (HR: 1.5), and vena cava involvement (HR: 3.1).
Conclusion
High‐impact targets for clinical and implementation trials in low‐resource settings include treatment abandonment, late presentation, and approaches optimized for healthcare systems with persistently unavailable radiotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Baylor College of Medicine, Houston, Texas, USA.
- University of North Carolina Project Malawi, Lilongwe, Malawi.
- Global Hematology-Oncology pediatric Excellence (HOPE), Houston, Texas, USA.
- Department of Outreach, Princess Maxima Center, Utrecht, Netherlands.
- Global Health Institute, Department of Epidemiology and Social Medicine, University of Antwerp, Belgium.
- Kamuzu University of Health Sciences, Blantyre, Malawi.
ORCID-Profile: David M Holmes, Minke H W Huibers, Mark Zobeck, Daniel C Aronson, Casey L McAtee
Förderung
- NCI NIH HHS
- NICHD NIH HHS
Zitieren
APA
Holmes, D. M., Matatiyo, A., Mpasa, A., Huibers, M. H. W., Manda, G., Tomoka, T., Mulenga, M., Namazzi, R., Mehta, P., Zobeck, M., Mzikamanda, R., Chintagumpala, M., Allen, C., Nuchtern, J. G., Borgstein, E., Aronson, D. C., Ozuah, N., Nandi, B., & McAtee, C. L. (2023). Outcomes of Wilms tumor therapy in Lilongwe, Malawi, 2016–2021: Successes and ongoing research priorities. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.30242
Vancouver
Holmes DM, Matatiyo A, Mpasa A, Huibers MHW, Manda G, Tomoka T, et al. Outcomes of Wilms tumor therapy in Lilongwe, Malawi, 2016–2021: Successes and ongoing research priorities. Pediatric Blood & Cancer. 2023. doi:10.1002/pbc.30242
BibTeX
@article{Holmes2023,
author = {Holmes, David M and Matatiyo, Apatsa and Mpasa, Atupele and Huibers, Minke H W and Manda, Geoffrey and Tomoka, Tamiwe and Mulenga, Maurice and Namazzi, Ruth and Mehta, Parth and Zobeck, Mark and Mzikamanda, Rizine and Chintagumpala, Murali and Allen, Carl and Nuchtern, Jed G and Borgstein, Eric and Aronson, Daniel C and Ozuah, Nmazuo and Nandi, Bip and McAtee, Casey L},
title = {Outcomes of Wilms tumor therapy in Lilongwe, Malawi, 2016–2021: Successes and ongoing research priorities},
journal = {Pediatric Blood & Cancer},
year = {2023},
doi = {10.1002/pbc.30242}
}
EUVIMED